Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
- PMID: 32533990
- PMCID: PMC7836896
- DOI: 10.1016/j.diabres.2020.108268
Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
Keywords: Anti-diabetic agents; COVID-19; Diabetes; Metformin; SARS-CoV-2.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Bornstein SR, Rubino Francesco, Khunti K, Mingrone G, Hopkins D, Birkenfeld A, et al. Practical recommendation Lancet Diab Endocrinol. https://doi.org/10.1016/S2213-8587(20)30152-2. - PubMed
-
- Sinclair A, Dhatariya K, Burr O, Nagi D, Higgins K, Hopkins D, et al. Guidelines for the management of diabetes in care homes during the Covid‐19 pandemic. Diabetic Med https://doi.org/10.1111/dme.14317. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
